In 2025, the average research and development cost to develop a new drug was **** billion U.S. dollars. The average R&D costs showed a fluctuating tendency over the last six years.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Deloitte. (April 24, 2026). Average cost to develop a compound for biopharma companies from 2013 to 2025 (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 16, 2026, from /statistics/1343554/randd-cost-to-develop-biopharma-compound/
Deloitte. "Average cost to develop a compound for biopharma companies from 2013 to 2025 (in billion U.S. dollars)." Chart. April 24, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 16, 2026. /statistics/1343554/randd-cost-to-develop-biopharma-compound/
Deloitte. (2026). Average cost to develop a compound for biopharma companies from 2013 to 2025 (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 16, 2026. /statistics/1343554/randd-cost-to-develop-biopharma-compound/
Deloitte. "Average Cost to Develop a Compound for Biopharma Companies from 2013 to 2025 (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 24 Apr 2026, /statistics/1343554/randd-cost-to-develop-biopharma-compound/
Deloitte, Average cost to develop a compound for biopharma companies from 2013 to 2025 (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1343554/randd-cost-to-develop-biopharma-compound/ (last visited July 16, 2026)
Average cost to develop a compound for biopharma companies from 2013 to 2025 (in billion U.S. dollars) [Graph], Deloitte, April 24, 2026. [Online]. Available: /statistics/1343554/randd-cost-to-develop-biopharma-compound/
